acute myeloid leukemiahealthcare resource utilizationcostrelapseContext AML is the most common form of acute leukemia in adults. The age-adjusted incidence of AML in the USA is 4.3/100,000 people, with median age of 68 years at diagnosis. Following diagnosis, treatment options include intensive ...
Type of hematological malignancy was determined using ICD-10 codes and was first classified in 11 categories: acute myeloid leukemia (AML), acute lymphoid leukemia (ALL), unknown type of acute leukemia, chronic lymphoid leukemia (CLL), multiple myeloma (MM), non-Hodgkin’s lymphoma (NHL), Hodg...
Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States. Pediatr Crit Care Med. 2014;15(2):112-120.PubMedGoogle ScholarCrossref 30. Lash TL, Fox MP, Fink AK. Applying Quantitative Bias Analysis to Epidemiologic Data. New York, NY: Springer; 2009...
A case of acute coronary syndrome manifesting as an adverse effect of all-trans retinoic acid in a lady with acute promyelocytic leukemia who had no other risk factors for cardiovascular disease [1A]. From: Side Effects of Drugs Annual, 2016 ...
We identified patients with acute leukemia (myeloid and lymphoid) and PEM using appropriate ICD-10 diagnostic codes. We stratified patients with acute leukemia based on the presence or absence of PEM. A survey multivariable logistic and linear regression analysis was used to calculate adjusted odds ...
We compared mortality among patients with and without COVID in 2020 using chi-square analysis.Results:Of 166795 admissions for acute leukemia, 71.8% were acute myeloid leukemia (AML), 25.2% were acute lymphoblastic leukemia (ALL) and 3.1% were acute promyelocytic leukemia (APML). Overall, ...
Aberrant DNA methylation is one of the most frequent alterations in patients with Acute Lymphoblastic Leukemia (ALL). Using methylation bead arrays we analyzed the methylation status of 807 genes implicated in cancer in a group of ALL samples at diagnosis (n = 48). We found that 154 genes ...
AML-117: The Economic Burden of Relapse in Acute Myeloid Leukemia (AML): A Retrospective Analysis of US Commercial and Medicare ClaimsAMLacute myeloid leukemiahealthcare resource utilizationcostrelapseContext AML is a malignant bone marrow cancer with substantial economic burden and poor prognosis. ...
acute myeloid leukemiaresource utilizationhospitalizationHEORHealthcare resource utilization and costs of managing AML patients are substantial, with hospitalization being the main cost driver of AML care. In the Phase 3 QUAZAR AML-001 maintenance trial, lower rates and durations of hospitalization with ...
Centre for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm 171 77, Sweden * Correspondence: sogawa-tky@umin.ac.jp; Tel.: +81-75-753-9285 Simple Summary: Recent genomic studies have identified chromatin-spliceosome (CS)-acute myeloid leukemia (AML) as a new subgroup of AML...